HSTM vs INDV: fair value comparison
HealthStream, Inc. and Indivior Pharmaceuticals, Inc. · Updated 2026-08-31
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, HSTM currently sits closer to the top of our discount ranking. HSTM carries the stronger quality grade.
| HSTM | INDV | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $28.33 | $37.37 |
| 12-month range | $20.37–$28.33 | $23.46–$40.25 |
| Sector rank | #25 of 113 Healthcare | #29 of 113 Healthcare |
| Quality grade | D | F |
| Momentum grade | B | — |
| Leverage | Low | Low |
| Margin trend | — | Stable |
| Revenue growth | — | Modest |
| RSI zone | Neutral | Oversold |
| 50/200-day trend | Uptrend | Mixed |
| DCF cross-check | — | Overvalued |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: HSTM fair value analysis · INDV fair value analysis